The Market Reports

Synopsis
The global market for Montelukast Sodium was estimated to be worth US$ 438 million in 2024 and is forecast to a readjusted size of US$ 1019 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Montelukast Sodium cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
The Montelukast Sodium market is experiencing significant growth, driven by the increasing global prevalence of respiratory conditions such as asthma and allergic rhinitis. As a leukotriene receptor antagonist, Montelukast Sodium effectively reduces inflammation and bronchoconstriction, making it a preferred treatment option. The market's expansion is further supported by the rising geriatric population, heightened awareness of respiratory health, and the affordability of generic alternatives following patent expirations. Additionally, the development of combination therapies and advancements in drug formulations are enhancing treatment efficacy and patient compliance. The COVID-19 pandemic also underscored the importance of respiratory medications, with studies suggesting Montelukast's potential in mitigating certain viral effects, thereby boosting its demand.
Regionally, North America holds a substantial share of the Montelukast Sodium market, attributed to its advanced healthcare infrastructure and high incidence of asthma. However, the Asia-Pacific region is projected to witness the fastest growth, fueled by increasing healthcare investments, urbanization, and a growing patient population. Despite the positive outlook, the market faces challenges such as pricing pressures from generic competition, potential side effects, and the emergence of alternative therapies. Nonetheless, ongoing research and development, coupled with strategic collaborations among pharmaceutical companies, are expected to sustain the market's upward trajectory.
This report aims to provide a comprehensive presentation of the global market for Montelukast Sodium, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Montelukast Sodium by region & country, by Type, and by Application.
The Montelukast Sodium market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Montelukast Sodium.
Market Segmentation
By Company
Morepen Laboratories
Mylan
TAPI
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Ortin Laboratories
Vamsi Labs
Adley Group
Arromax Pharmaceutical Technology
Lunan
Dongyue
Anxin
Segment by Type
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Segment by Application
Tablets
Chewable Tablet
Oral Solution
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Montelukast Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Montelukast Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Montelukast Sodium in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index